These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16766391)

  • 1. Immunological detection of nitrosative stress-mediated modified Tamm-Horsfall glycoprotein (THP) in calcium oxalate stone formers.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Anandkumar P; Varalakshmi P
    Biomarkers; 2006; 11(2):153-63. PubMed ID: 16766391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional modification of THP on nitration: comparison with stone formers THP.
    Pragasam V; Kalaiselvi P; Subashini B; Sumitra K; Varalakshmi P
    Nephron Physiol; 2005; 99(1):p28-34. PubMed ID: 15637470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.
    Schnierle P; Hering F; Seiler H
    Urol Res; 1996; 24(2):79-82. PubMed ID: 8740976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy.
    Knörle R; Schnierle P; Koch A; Buchholz NP; Hering F; Seiler H; Ackermann T; Rutishauser G
    Clin Chem; 1994 Sep; 40(9):1739-43. PubMed ID: 8070085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers.
    Schnierle P
    Experientia; 1995 Nov; 51(11):1068-72. PubMed ID: 7498447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamm-Horsfall glycoprotein and calcium nephrolithiasis.
    Hess B
    Miner Electrolyte Metab; 1994; 20(6):393-8. PubMed ID: 7783702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
    Hess B
    Urol Res; 1992; 20(1):83-6. PubMed ID: 1736492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M; Mulinari RA; Nakagawa Y
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients.
    Sumitra K; Pragasam V; Sakthivel R; Kalaiselvi P; Varalakshmi P
    Nephrol Dial Transplant; 2005 Jul; 20(7):1407-15. PubMed ID: 15855216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation.
    Hess B; Zipperle L; Jaeger P
    Am J Physiol; 1993 Dec; 265(6 Pt 2):F784-91. PubMed ID: 8285211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Tamm-Horsfall protein in stone-forming rat models.
    Miyake O; Yoshioka T; Yoshimura K; Honda M; Yamaguchi S; Koide T; Okuyama A
    Br J Urol; 1998 Jan; 81(1):14-9. PubMed ID: 9467470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Tamm-Horsfall protein in lithiasic patients.
    Romero MC; Nocera S; Nesse AB
    Clin Biochem; 1997 Feb; 30(1):63-7. PubMed ID: 9056112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
    Atmani F; Glenton PA; Khan SR
    Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoelectric focusing of native urinary uromodulin (Tamm-Horsfall protein) shows no physicochemical differences between stone formers and non-stone formers.
    Trewick AL; Rumsby G
    Urol Res; 1999 Aug; 27(4):250-4. PubMed ID: 10460894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both.
    Mo L; Liaw L; Evan AP; Sommer AJ; Lieske JC; Wu XR
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1935-43. PubMed ID: 17898038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemistry of urinary calcium oxalate crystal growth inhibitor (CGI).
    Lopez M; Nakagawa Y; Coe FL; Tsai C; Michael AF; Scheinman JI
    Kidney Int; 1986 Apr; 29(4):829-33. PubMed ID: 3520093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.